Pirarubicin-based versus doxorubicin-based osteosarcoma chemotherapy

Annals of Pharmacotherapy

Volumn 36, Issue 6, 2002, Pages 996-999

  Shinozaki, Tetsuya ^a   Watanabe, Hideomi ^a   Yanagawa, Takashi ^a   Shirakura, Kenji ^a   Takagishi, Kenji ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Combination chemotherapy; Doxorubicin; Osteosarcoma; Tetrahydropyranyladriamycin

Indexed keywords

BLEOMYCIN; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; PIRARUBICIN; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; MUCOSA INFLAMMATION; OSTEOSARCOMA; PRIORITY JOURNAL; SCHOOL CHILD; TOXICITY; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; CHILD; COMPARATIVE STUDY; GASTROINTESTINAL DISEASE; MIDDLE AGED; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; DOXORUBICIN; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036014067     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A187     Document Type: Article

References (23)

1. A system for the surgical staging of musculoskeletal sarcoma
2. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: A study of the European Osteosarcoma Intergroup
3. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation: Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesion
4. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
5. Phase II evaluation of adriamycin in human neoplasia
6. Adriamycin - An antitumor antibiotic in the treatment of neoplastic diseases
7. Phase II trial of 4′-O-tetrahydropyranyladriamycin (Pirarubicin) in head and neck carcinoma
8. Combination chemotherapy with pirarubicin (THP), cyclophosphamide, vincristine, and prednisolone (VEP-THP therapy) in the treatment of non-Hodgkin's lymphoma
9. Clinical study of Pirarubicin for breast cancer in Japan
10. Early assessment of a new anticancer drug analogue - Are the historical comparisons obsolete? The French experience with pirarubicin
11. Toxic effects
12. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: Comparison of new analogues versus doxorubicin
13. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat
14. Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy
15. High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma
16. High-dose ifosfamide in advanced osteosarcoma
17. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: The M.D. Anderson experience
18. A Phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas
19. Vincristine in the treatment of lymphomas and leukemias
20. Radiation and combination chemotherapy in advanced Ewing's sarcoma - Intergroup study
21. Ewing's sarcoma. A retrospective study of prognostic factors and treatment results
22. Nonparametric estimation from incomplete observations
23. Trends and variability in survival from osteosarcoma